How the COVID-19 pandemic influences the prevalence of pressure injuries in the Czech Republic: A nationwide analysis of a health registry in 2020
Jazyk angličtina Země Anglie, Velká Británie Médium print-electronic
Typ dokumentu časopisecké články
PubMed
35725785
PubMed Central
PMC9197563
DOI
10.1016/j.jtv.2022.06.003
PII: S0965-206X(22)00060-2
Knihovny.cz E-zdroje
- Klíčová slova
- COVID-19, Epidemiology, Hospitalization, Inpatient care, Pressure injuries, Prevalence,
- MeSH
- COVID-19 * epidemiologie MeSH
- dekubity * MeSH
- drtivá poranění * MeSH
- hospitalizace MeSH
- lidé MeSH
- pandemie MeSH
- prevalence MeSH
- průřezové studie MeSH
- registrace MeSH
- retrospektivní studie MeSH
- SARS-CoV-2 MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- Geografické názvy
- Česká republika epidemiologie MeSH
BACKGROUND: COVID-19 significantly influences the overall patient status and, in severe symptomatology, the ability to move and the low oxygenation of the tissue for the ventilated patient in Intensive Care Units (ICU). There is a higher risk for Pressure injuries (PIs) development. OBJECTIVES: The nationwide analyses of the National health register aimed to compare the prevalence of PIs reported before the pandemic COVID-19 started and during the pandemic in 2020. METHOD: A retrospective, nationwide cross-sectional analysis of data regarding the STROBE checklist collected by the National Health Information System (NHIS), focusing on the PIs reporting based on the International Classification of Diseases (ICD-10) diagnoses L89.0-L89.9 for PIs in 2020. The data from the pandemic period of COVID-19 in 2020 were compared to the prevalence of PI cases in the period 2010-2019 in the Czech Republic in all hospitalized patients. RESULTS: The total number of admissions for L89 in 2020 was 14,441, of which 1509 (10.4%) also had COVID-19. In the ICU were 4386 admissions, 12.1% of which also had COVID-19. A higher proportion of PIs is observed in patients hospitalized with COVID-19 than in patients without COVID-19 (2.62% vs 0.81%, respectively 1.05% vs 0.46% when standardized to the 2013 ESP = European Standard Population). In patients hospitalized in ICU, 3.68% with COVID-19 had PIs vs 1.42% without COVID-19 had PIs (1.97% vs 0.81% using the 2013 ESP). CONCLUSION: The national health registers analyses have proven that the prevalence of PIs was higher among patients hospitalized with the SARS-CoV-2 infection.
Zobrazit více v PubMed
Organization W.H Coronavirus disease 2019(COVID-19) situation report-51. 2020. https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200311-sitrep-51-covid-19.pdf?sfvrsn=1ba62e57_10 Available from:
Guzik T.J., Mohiddin S.A., Dimarco A., Patel V., Savvatis K., Marelli-Berg F.M., Madhur M.S., Tomaszewski M., Maffia P., D'Acquisto F., Nicklin S.A., Marian A.J., Nosalski R., Murray E.C., Guzik B., Berry C., Touyz R.M., Kreutz R., Wang D.W., Bhella D., Sagliocco O., Crea F., Thomson E.C., McInnes I.B. COVID-19 and the cardiovascular system: implications for risk assessment, diagnosis, and treatment options. Cardiovasc Res. 2020;116(10):1666–1687. doi: 10.1093/cvr/cvaa106. PubMed DOI PMC
Zhu H., Rhee J.W., Cheng P., Waliany S., Chang A., Witteles R.M., Maecker H., Davis M.M., Nguyen P.K., Wu S.M. Cardiovascular complications in patients with COVID-19: consequences of viral toxicities and host immune response. Curr Cardiol Rep. 2020;22(5):32. doi: 10.1007/s11886-020-01292-3. PubMed DOI PMC
Riad A., Klugar M., Krsek M. COVID-19-Related oral manifestations: early disease features? Oral Dis. 2020 doi: 10.1111/odi.13516. 10.1111/odi.13516. PubMed DOI PMC
Hocková B., Riad A., Valky J., Šulajová Z., Stebel A., Slávik R., Bečková Z., Pokorná A., Klugarová J., Klugar M. Oral complications of ICU patients with COVID-19: case-series and review of two hundred ten cases. J Clin Med. 2021;10(4):581. doi: 10.3390/jcm10040581. PubMed DOI PMC
Riad A., Kassem I., Hockova B., Badrah M., Klugar M. Tongue ulcers associated with SARS-CoV-2 infection: a case series. Oral Dis. 2020 doi: 10.1111/odi.13635. PubMed DOI
Riad A., Kassem I., Hockova B., Badrah M., Klugar M. Halitosis in COVID-19 patients. Spec Care Dent. 2021;41(2):282–285. doi: 10.1111/scd.12547. PubMed DOI PMC
Riad A., Gad A., Hockova B., Klugar M. Oral candidiasis in non-severe COVID-19 patients: call for antibiotic stewardship. Oral Surg. 2020;21 doi: 10.1111/ors.12561. 10.1111/ors.12561. PubMed DOI PMC
Riad A, Gomaa E, Hockova B, Klugar M. Oral candidiasis of COVID-19 patients: case report and review of evidence. J Cosmet Dermatol 202;20(6):1580-1584. doi: 10.1111/jocd.14066. PubMed PMC
Riad A., Kassem I., Badrah M., Klugar M. Acute parotitis as a presentation of COVID-19? Oral Dis. 2020 doi: 10.1111/odi.13571. PubMed DOI
Riad A., Kassem I., Badrah M., Klugar M. The manifestation of oral mucositis in COVID-19 patients: a case-series. Dermatol Ther. 2020;33(6) doi: 10.1111/dth.14479. PubMed DOI PMC
Riad A., Kassem I., Issa J., Badrah M., Klugar M. Angular cheilitis of COVID-19 patients: a case-series and literature review. Oral Dis. 2020;11 doi: 10.1111/odi.13675. 10.1111/odi.13675. PubMed DOI PMC
Riad A., Kassem I., Stanek J., Badrah M., Klugarova J., Klugar M. Aphthous stomatitis in COVID-19 patients: case-series and literature review. Dermatol Ther. 2021;34(1) doi: 10.1111/dth.14735. PubMed DOI PMC
Al-Khanati N.M., Riad A., Sahloul M.E., Klugar M. Aphthous-like stomatitis of COVID-19 patients. Braz J Oral Sci. 2020;19
Wollina U., Karadağ A.S., Rowland-Payne C., Chiriac A., Lotti T. Cutaneous signs in COVID -19 patients: a review. Dermatol Ther. 2020:33. PubMed PMC
Wollina U. Challenges of COVID-19 pandemic for dermatology. Dermatol Ther. 2020;33 PubMed PMC
Abrams J.Y., Godfred-Cato S.E., Oster M.E., Chow E.J., Koumans E.H., Bryant B., Leung J.W., Belay E.D. Multisystem inflammatory syndrome in children associated with severe acute respiratory syndrome coronavirus 2: a systematic review. J Pediatr. 2020;226 doi: 10.1016/j.jpeds.2020.08.003. 45-54.e1. PubMed DOI PMC
Sianes-Gallén M., Pujol-García A.M., Rus García M., Partera Luque C., López Postigo M., Call Mañosa S., Camposo Montesino M.C., Ibáñez Touriño B., Ribas Obon E., Segura Rodríguez T., Cores Fuentes P., Tamame Sanantonio M., Jornet-Gibert M. Pressure injuries during the SARS-CoV-2 pandemic: a retrospective, case-control study. J Tissue Viability. 2021;30(4):478–483. doi: 10.1016/j.jtv.2021.07.011. PubMed DOI PMC
Gefen A., Brienza D.M., Cuddigan J., Haesler E., Kottner J. Our contemporary understanding of the aetiology of pressure ulcers/pressure injuries. Int Wound J. 2022;19(3):692–704. doi: 10.1111/iwj.13667. PubMed DOI PMC
Von Elm E., Altman D.G., Egger M., Pocock S.J., Gøtzsche P.C., Vandenbroucke J.P. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. UroToday Int J. 2007;335(7624):806–808. doi: 10.1136/bmj.39335.541782.ad. PubMed DOI PMC
Revision of the European standard population - report of eurostat's task force - 2013 edition. European Union; 2013. DOI
Pokorná A., Štrombachová V., Mužík J., Dolanová D., Búřilová P., Pospíšil M., Kučerová J., Gregor J., Komenda M., Dušek L. Institute of Health Information and Statistics of the Czech Republic; Prague: 2016. National portal Adverse event reporting system [online]https://shnu.uzis.cz Available from:
Johnson C., Giordano N.A., Patel L., Book K.A., Mac J., Viscomi J., Em A., Westrick A., Koganti M., Tanpiengco M., Sylvester K., Mastro K.A. Pressure injury outcomes of a prone-positioning protocol in patients with COVID and ARDS. Am J Crit Care. 2022;31(1):34–41. doi: 10.4037/ajcc2022242. PubMed DOI
Nieto-García L., Carpio-Pérez A., Moreiro-Barroso M.T., Ruiz-Antúnez E., Nieto-García A., Alonso-Sardón M. Are there differences between COVID-19 and non-COVID-19 inpatient pressure injuries? Experiences in Internal Medicine Units. PLoS One. 2022;17(2) doi: 10.1371/journal.pone.0263900. PubMed DOI PMC
Montgomery A.P., Patrician P.A., Hall A., Miltner R.S., Enogela E.M., Polancich S. Modeling patient risk for hospital-acquired pressure injuries during COVID-19: a retrospective study. J Nurs Care Qual. 2022;37(2):162–167. doi: 10.1097/NCQ.0000000000000602. PubMed DOI PMC
Pepera G., Tribali M.S., Batalik L., Petrov I., Papathanasiou J. Epidemiology, risk factors and prognosis of cardiovascular disease in the Coronavirus Disease 2019 (COVID-19) pandemic era: a systematic review. Rev Cardiovasc Med. 2022;23(1):28. doi: 10.31083/j.rcm2301028. PubMed DOI
Gannon R., Fowles J.-A., Gerrard C., Scott B. Prevalence of skin injuries in COVID-19 patients in a specialist UK respiratory Intensive Care Unit. Wounds U K. 2021;17(4):56–66.
Kendall J.A., Haberl J.K., Hartsgrove C., Murphy L.F., DeLuca R., Diaz-Segarra N., Kirshblum S.C. Surveillance for pressure injuries on admission to inpatient rehabilitation hospitals during the COVID-19 pandemic. Arch Phys Med Rehabil. 2021;102(10):1932–1938. doi: 10.1016/j.apmr.2021.06.011. PubMed DOI PMC
Vowden K., Hill L. What is the impact of COVID-19 on tissue viability services and pressure ulceration? J Wound Care. 2021;30(7):522–531. doi: 10.12968/jowc.2021.30.7.522. PubMed DOI
Polancich S., Hall A.G., Miltner R., Poe T., Enogela E.M., Montgomery A.P., Patrician P.A. Learning during crisis: the impact of COVID-19 on hospital-acquired pressure injury incidence. J Healthc Qual. 2021;43(3):137–144. doi: 10.1097/JHQ.0000000000000301. PubMed DOI PMC
Changes in gene expression in pressure ulcers debrided by different approaches - a pilot study